We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Oxford Biodynamics Plc | LSE:OBD | London | Ordinary Share | GB00BD5H8572 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.02 | -3.08% | 0.63 | 0.60 | 0.70 | 0.65 | 0.65 | 0.65 | 2,627,564 | 16:35:10 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.34M | -10.83M | -0.0347 | -0.19 | 2.03M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/1/2025 07:55 | Where’s that fool boysie 72 🤡📉 | ny boy | |
14/1/2025 22:42 | How did Iain Ross's turnaround at RENE go Soiled his record (so far) | thiopia | |
14/1/2025 17:48 | 6m won't cut it I'm afraid redundancies etc would decimate that . They are too far gone at this stage and without immediate huge cuts will just end up begging for cash again . Break even os a very long way off will take years even at reduced cost base | bones698 | |
14/1/2025 17:34 | They've got a turnaround specialist on board (Iain Ross) with a remit to stabilise the company and get it onto a breakeven basis. | jaknife | |
14/1/2025 17:22 | Lmao so 0.5p or bust . Won't last them long unfortunately and will be back in the same situation with no willing buyers and noncash left . Just prolonging the inevitable here I'm afraid | bones698 | |
14/1/2025 14:16 | Looks like will end up in admin . Poor management no cost controls just blew the money | bones698 | |
24/12/2024 09:44 | You would have thought that on Christmas Eve of all days, the directors of OBD might have said, instead of allotting themselves yet more shares in lieu of salary, “Having presided over a 90% share price fall since the last placing less than a year ago which was carried out using wildly over optimistic assumptions, the directors on this occasion are waiving their entitlement to shares in lieu of salary as a seasonal gesture to our long suffering shareholders”. Happy Christmas!! | bowerdean | |
19/12/2024 15:04 | Thebd11 totally agree they will try all avenues but it will come back to fund raise to keep going . The problem here is they never cut costs and kept blowing cash for fun . For me the tech may be good but the management have destroyed any chance of it's success . Will send up in admin and someone else likely but the IP and use it to much better effect Eve if they raise 5m at 0.2p it won't last 6 months that is getting problem here ,they won't be able to raise much more given the mkt cap either . It's already to late for investors imo | bones698 | |
19/12/2024 09:34 | My guess is this will raise at sub 0.2p, maybe 0.1. Current equity holders wiped out unfortunately, new management shuts this thing down except for US sales team promoting the prostate testing. 2 years cash raised, take a run at the PSE, minimise expenses. Would imagine they'll explore sale of almost any other asset, but this will take some time and in an immediate case will need to shut down expenditure related to developing any other tests. I'll maybe meet with Ian in the new year and see whether this is the case, but it doesn't look good for the existing equity that's for sure, sadly. | thebd11 | |
16/12/2024 17:34 | Matthew Wakefield, Chairman of Oxford BioDynamics said: "On behalf of the Board, I would like to thank Jon for his contribution to the Company over the last four years. In that time, Jon has led the Company from being predominantly R&D focused to a position where we now have two tests on the market" That sounds better than he's led the share price from £1 four years ago to 1p now! | elpirata | |
16/12/2024 08:20 | Yep will get forward sold and drop to around 0?5p then a discount for the placing so anything from 0.2p possible here now . No upside at all | bones698 | |
16/12/2024 08:06 | Will get walked down in coming weeks as the placing gets arranged at a much lower price . Holders getting wiped out . Should have listened | bones698 | |
16/12/2024 07:03 | Will get slaughtered today as equity fund raise will be around 0.2-0.5p . There simply is no money for these type of companies other then equity raises which is highly dillutive . | bones698 | |
04/12/2024 08:33 | Yup it's suckered in a load yesterday and they will.makena loss today suckers | bones698 | |
08/11/2024 14:28 | Bones is a bellwether to do the exact opposite . He seems to go round all advfn being a complete bellend | moontheloon |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions